Advances in Immuno-Oncology

    Dr Robert Weinkove, Consultant Haematologist at Wellington Blood and Cancer Centre and Clinical Director at Malaghan Institute of Medical Research introduces the topic of immuno-oncology.  He discusses current and emerging classes of cancer immunotherapies and gives an overview of their mechanisms of action, current place in treatment and recognition of adverse effects in primary care.
     

    Immunotherapy for advanced melanoma: clinical outcomes

    Dr Rosalie Stephens is a medical oncologist at Auckland Hospital with a special interest in treating melanoma and is a Trustee on the board of Melanoma NZ. In this video podcast Dr Stephens describes the clinical outcomes achieved with immunotherapy for advanced melanoma.

    Toxicity of immune checkpoint inhibitors: Immune related side effects

    Dr Rosalie Stephens is a medical oncologist at Auckland Hospital with a special interest in treating melanoma and is a Trustee on the board of Melanoma NZ. In this video podcast Dr Stephens describes some of the side effects produced by the immune checkpoint inhibitor class of treatments.
     

    The Future of Immuno-Oncology

    Dr Robert Weinkove, Consultant Haematologist at Wellington Blood and Cancer Centre and Clinical Director at Malaghan Institute of Medical Research discusses the future of immuno-oncology. He outlines new treatment modalities and new combinations of immuno-oncology agents with conventional treatments.